Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 3,896,405	$ 2,538,758
Short term investments	2,956,428	7,399,636
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at June 30, 2015 and December 31, 2014	809,387	901,623
Inventories	1,321,257	965,224
Prepaid expenses and other current assets	313,412	360,521
Total current assets	9,296,889	12,165,762
Property and equipment
Leasehold improvements	1,284,491	1,284,491
Furniture and computer equipment	514,056	476,788
Manufacturing and other equipment	1,007,127	972,386
Subtotal	2,805,674	2,733,665
Less: Accumulated depreciation	(1,246,787)	(1,078,060)
Net property and equipment	1,558,887	1,655,605
Internal use software	762,860	0
Intangible asset	2,215,385	2,215,385
Long term deposits	36,166	36,166
Total assets	13,870,187	16,072,918
Current liabilities
Accounts payable	640,271	474,662
Accrued expenses and other current liabilities	62,741	121,869
Accrued compensation	326,928	535,029
Deferred rent	130,216	130,216
Total current liabilities	1,160,156	1,261,776
Long term liabilities
Deferred rent, long term	832,976	874,825
Total liabilities	$ 1,993,132	$ 2,136,601
Commitments and Contingencies (Note 10)
Shareholders' equity (deficiency)
Common stock, $0.001 par value; 150,000,000 shares authorized,12,154,858 and 12,084,859 shares issued and outstanding at June 30, 2015 and December 31, 2014	$ 12,154	$ 12,084
Additional paid-in capital	72,149,598	71,911,328
Accumulated other comprehensive loss	(1,390)	(6,448)
Accumulated deficit	(62,138,848)	(60,112,987)
Total BioLife Solutions, Inc. shareholders' equity	10,021,514	11,803,977
Total non-controlling interest equity	1,855,541	2,132,340
Total shareholders' equity	11,877,055	13,936,317
Total liabilities and shareholders' equity	$ 13,870,187	$ 16,072,918